Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01669031
Other study ID # Oftalmo_Glaucoma_002
Secondary ID
Status Recruiting
Phase N/A
First received August 16, 2012
Last updated August 16, 2012
Start date August 2012
Est. completion date May 2013

Study information

Verified date August 2012
Source Oftalmologia Hospital Sotero del Rio
Contact Justin B Hellman, Bachelors
Phone 67313177
Email justin@tentacle.net
Is FDA regulated No
Health authority Chile: Marcelo Coria, Jefe de Servicio de Oftalmologia, Hospital Sotero del Rio.
Study type Interventional

Clinical Trial Summary

Unreliability and visual field variability is a known problem with automated perimetry in both developing and developed country settings. This study will look at the effects of a computer program that allows new patients to practice the visual field exam before taking the actual exam. Our hypothesis is that the intervention group will have less variability as measured by mean deviation between exams and greater reliability as measured by the standard unreliability indexes of false positive rate, false negative rate, and fixation losses.


Description:

3 study visits. Visit 1: Baseline visit for consent, getting baseline data and finally randomizing the patient. Those randomized to intervention get their first session of simulated visual field (2 per eye) on a regular computer for training purposes.

Visit 2: 1 to 2 days after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field Visit 3: 1 to 2 weeks after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field.

Study Ends, patient gets seen by the patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years old or greater

- Referred to the glaucoma clinic for examination due to suspected glaucoma or glaucoma diagnosis

- No more than 1 automated visual field test within the last 4 years

Exclusion Criteria:

- patients who cannot remain seated for 10 minutes

- patients with neck problems that prevent them from using the field analyzer properly

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Practice program
Each practice session (simulated visual field test on computer) takes 3-15 minutes

Locations

Country Name City State
Chile Hospital Sótero del Río Santiago Puente Alto

Sponsors (1)

Lead Sponsor Collaborator
Oftalmologia Hospital Sotero del Rio

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Primary The absolute value of the difference in mean deviation of the first and second visual field exam Visual field exams obtained 1 to 2 weeks apart No
Secondary Difference in the absolute number of altered points in the visual field with a total deviation below the 0.5 percentile Visual field exams obtained 1 to 2 weeks apart No
Secondary Difference in the percentage of false positives, false negatives, and fixation losses at the first and second exam between control and intervention group Visual field exams obtained 1 to 2 weeks apart No
Secondary Difference in the time required to complete the first and second exam Visual field exams obtained 1 to 2 weeks apart No
Secondary Difference in the proportion of unreliable visual fields at the first and second exam between control and intervention groups Visual field exams obtained 1 to 2 weeks apart No
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A
Completed NCT02520674 - Glaucoma Screening With Smartphone Ophthalmology N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A